FDA Works to Protect Consumers from Foodborne Illness and other Adverse Events

FDA

A Conversation with Stic Harris, Conrad Choiniere, and Michael Rogers on Foodborne Illness and other Adverse Events 

Each year, the FDA receives approximately 9,600 reports of foodborne illness or other adverse events related to FDA-regulated human food and dietary supplement products submitted by individual consumers, public health professionals, or industry.[1] In addition, the FDA’s Coordinated Outbreak Response & Evaluation (CORE) Network evaluates an average of 75 incidents annually that may potentially constitute a national, multi-state outbreak. 

The FDA takes its responsibility to safeguard the food supply very seriously and is committed to being transparent about how FDA approaches its food safety mission, particularly about how the agency responds when it receives reports of foodborne illness and other adverse events.   

That is what three foods program leaders will discuss in this conversation about challenges and opportunities they face every day in working to protect consumers from potential hazards in the complex, global food system.

Stic Harris, DVM, MPH, is the director of FDA’s Coordinated Outbreak Response & Evaluation (CORE) Network, which is on the frontline of foodborne illness outbreak investigations.

Conrad Choiniere, Ph.D., is the director of the Office of Analytics and Outreach at FDA’s Center for Food Safety and Applied Nutrition (CFSAN). His office evaluates consumer complaints and reports of potential hazards associated with FDA-regulated food, dietary supplements and cosmetic products.

Michael Rogers, MS, is the Assistant Commissioner for Human and Animal Food Operations in FDA’s Office of Regulatory Affairs (ORA), the inspection and enforcement arm of the FDA. In his role he works with ORA’s consumer complaint coordinators and investigators in the field, who are the agency’s boots on the ground in this work to keep foods safe.

These three leaders represent different aspects of the agency’s food safety work and, together, they will provide an overview of how FDA is doing its job and what it can, and will, do to continually improve in this space.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s